Search clinical trials for: Iodinated Active Charcoal (IodoCarb)

Total 103 results

PharmaLundensis AB

Completed

Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Iodinated Activated Charcoal

Chronic Obstructive Lung Disease

Sweden
National Taiwan University Hospital

Recruiting

Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease

CKD

Taiwan
National Taiwan University Hospital

Recruiting

lncRNAs as a Biomarker to Assess the Therapeutic Impact of Oral Absorbent ± Probiotics in CKD Patients With PAD

CKD | PAD

Taiwan
National Taiwan University Hospital

Recruiting

Oral Absorbent and Probiotics in CKD Patients With PAD on Gut Microbiota, IncRNA, Metabolome, and Vascular Function

CKD | PAD - Peripheral Arterial Disease

Taiwan
Zambon SpA

Completed

A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy Volunteers

Asthma

United Kingdom
Zambon SpA

Completed

Clinical Study to Evaluate Z7200 Pharmacokinetics Profile

Asthma

United Kingdom
Orion Corporation, Orion Pharma

Completed

Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference Product (FORELLI)

Healthy Volunteers

Finland
GlaxoSmithKline

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK2269557 Administered Via the ELLIPTA Dry Powder Inhaler to Healthy Subjects

Pulmonary Disease, Chronic Obstructive

United States
Cairo University

Not yet recruiting

Enamel Abrasion and Stain Removal Efficacy of Two Whitening Toothpastes: An In-vitro and In-vivo Trial

Tooth Abrasion
Centre Hospitalier Universitaire de Saint Etienne

Completed

Non Inferiority Study of a Reduced Dose of Activated Charcoal on Rivaroxaban Pharmacokinetics. (RICHAR2)

Healthy

France
University of Jaen
University of Miami; University Rovira i Virgili; Universidad Miguel Hernandez...

Completed

Indicated Prevention Transdiagnostic Intervention for Adolescents At High Risk of Emotional Problems (PROCARE-I)

Depressive Symptoms | Anxiety Disorders and Symptoms

Spain
Cairo University

Not yet recruiting

Enamel Abrasion and Stain Removal Efficacy

Discoloration, Tooth | Abrasion
Centre Hospitalier Universitaire de Saint Etienne

Completed

Effect of Activated Charcoal on Rivaroxaban Pharmacokinetics in Healthy Subjects (RICHAR)

Healthy

France
Sunovion Respiratory Development Inc.

Completed

Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). (GOLDEN7)

COPD

United Kingdom
Novartis Pharmaceuticals

Available

Managed Access Programs for PKC412, Midostaurin

Acute Myeloid Leukemia | Mast Cell Leukemia | Aggressive Systemic Mastocytosis | Systemic Mastocytosis With an Associated Hematologic Neoplasm | FMS-Like Tyrosine Kinase 3 (FLT3)-Mutated Acute Myeloid Leukemia
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study Comparing Tiotropium Easyhaler® and Spiriva® HandiHaler® (TESSA)

Healthy Volunteers

Finland
Orion Corporation, Orion Pharma

Completed

Absorption of Indacaterol and Glycopyrronium From Ultibro Breezhaler (FINDA)

Healthy Volunteers

Finland
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte (ADECO)

Asthma

Germany
GlaxoSmithKline

Completed

Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.

Asthma

Australia
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
GlaxoSmithKline
Sanofi

Completed

OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction

Thromboembolism
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Asthma

Finland
Cedars-Sinai Medical Center
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Terminated

Hookah Smoking, Carbon Monoxide, and Coronary Endothelial Function

Smoking | Endothelial Dysfunction

United States
Sanofi

Completed

Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis (TERI-DYNAMIC)

Multiple Sclerosis

Belgium, Germany, Netherlands
AstraZeneca
Parexel

Completed

Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI HFO Compared With BGF MDI HFA

Chronic Obstructive Pulmonary Disease

United States
University Hospital, Caen

Completed

Performance of PET 18 F-FDG Coupled to CT With Contrast Injection Iodized in the Diagnosis of Early Recurrences of Head and Neck Carcinoma Treated With Concurrent Chemoradiation. Comparison With 18F-FDG PET Coupled With CT Not Injected With Filling CT Standard Injection (TEPVAD)

Squamous Cell Carcinoma of the Head and Neck

France
European Organisation for Research and Treatment...

Completed

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Sarcoma | Small Intestine Cancer | Ovarian Cancer | Endometrial Cancer | Gastrointestinal Stromal Tumor

France, Denmark, Netherlands, Belgium, United Kingdom
Sanofi

Recruiting

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis

United States, Canada, Puerto Rico, United Kingdom
European Organisation for Research and Treatment...

Completed

Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma

Sarcoma

France, Belgium, Netherlands, United Kingdom
Novartis Pharmaceuticals

Completed

An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

United States, Germany, United Kingdom, Italy, France, Switzerland
University of Michigan
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Comparison of Alveolar Macrophages in Individuals With COPD Versus Smokers With Normal Pulmonary Function

Lung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive

United States
National Taiwan University Hospital
Hoffmann-La Roche

Unknown

Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C

Hepatitis C, Chronic | Hepatitis B, Chronic

Taiwan
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhaler

Healthy

Finland
Dong Il Park, M.D, Ph.D.

Unknown

Comparison of Low-volume PEG Plus Ascorbic Acid Versus Standard PEG Solution as Bowel Cleansing for Colonoscopy

Colonoscopy [E01.370.372.250.250.200]

Korea, Republic of
Johns Hopkins University

Completed

Apixaban Pharmacokinetics in Bariatric Patients (APB) (APB)

Obesity | Bariatric Surgery

United States
Hadassah Medical Organization
Soroka University Medical Center

Unknown

Ascorbic Acid Treatment in Congenital Glucocorticoids and Mineralocorticoids Deficiency Due to NNT Mutation

Glucocorticoids Deficiency

Israel
Idorsia Pharmaceuticals Ltd.

Completed

To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men.

Healthy Subjects

France
Sun Yat-sen University

Unknown

IV Ascorbic Acid in Advanced Gastric Cancer

Gastric Cancer

China
Yonsei University

Unknown

High-dose Ascorbic Acid Intravenous Injection Decreases Mitochondrial DNA Damage in Chronic Fatigue Patients: Randomized-controlled Study

Chronic Fatigue

Korea, Republic of
Instituto de Investigacion Sanitaria La Fe
Bristol-Myers Squibb

Terminated

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Venous Thromboembolism

Spain
Mayo Clinic
Bristol-Myers Squibb

Withdrawn

Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli (PARADOX)

Patent Foramen Ovale | Cardiac Implantable Electronic Device

United States
Debiopharm International SA

Completed

Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants

Chronic Pain | Hepatitis C

United States, Belgium, Germany, Taiwan, Australia, France, Thailand, Puerto Rico, United Kingdom, Italy, India, Poland, Korea, Republic of, Canada
Respirent Pharmaceuticals Co Ltd.
Becro Ltd.

Completed

A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade (BREATH-PK250-CC)

Bioequivalence

Greece
Universitaire Ziekenhuizen KU Leuven
Bristol-Myers Squibb

Completed

Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study

ESRD | Anticoagulant Toxicity

Belgium
Assistance Publique - Hôpitaux de Paris
Group for Research in Adult Acute Lymphoblastic Leukemia

Completed

Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults

Leukemia, Lymphocytic

France
National Cancer Center, Korea

Completed

The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation

Bladder Cancer

Korea, Republic of
Pfizer
Bristol-Myers Squibb

Completed

A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation

Atrial Fibrillation

Japan
Sanofi

Completed

Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female Subjects

Type 2 Diabetes Mellitus | Healthy Subjects

United Kingdom

3

Subscribe